A retroviral-derived peptide phosphorylates protein kinase D/protein kinase Cμ involving phospholipase C and protein kinase C u_net

Peptides

Volumn 24, Issue 5, 2003, Pages 631-637

  Luangwedchakarn, Voravich ^a,c   Day, Noorbibi K ^a   Hitchcock, Remi ^a   Brown, Pam G ^a   Lerner, Danica L ^a   Rucker, Rajivi P ^a   Cianciolo, George J ^b   Good, Robert A ^a   Haraguchi, Soichi ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

CKS 17; Human; Jurkat T cell line; Protein kinase C ; Protein kinase D; Retroviral transmembrane protein; Signal transduction; Synthetic peptide

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CELL EXTRACT; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; LEUCYLGLUTAMINYLASPARAGINYLLYSYLLYSYLGLYCYLLEUCYLASPARTYLLEUCYLLEUCYLPHENYL ALANYLLEUCYLLYSYLGLUTAMYLGLYCYLGLYCYLLEUCYLCYSTEINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PEPTIDE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C MU; PROTEIN KINASE D; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; MOLECULAR INTERACTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 0041704717     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(03)00137-2     Document Type: Article

References (44)

1. Bacon K.B., Camp R.D. Interleukin (IL)-8-induced in vitro human lymphocyte migration is inhibited by cholera and pertussis toxins and inhibitors of protein kinase C. Biochem. Biophys. Res. Commun. 169:1990;1099-1104.
2. Bligh E.A., Dyer W.J. A rapid method of total lipid extraction and purification. Can J. Biochem. Physiol. 37:1959;911-917.
3. Bowden E.T., Barth M., Thomas D., Glazer R.I., Mueller S.C. An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation. Oncogene. 18:1999;4440-4449.
4. Bradford M.D., Soltoff S.P. P2X7 receptors activate protein kinase D and p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C. Biochem. J. 366:2002;745-755.
5. Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T.et al. Inhibiton of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:1990;5267-5272.
6. Cianciolo G.J., Bogerd H., Snyderman R. Human retrovirus-related synthetic peptides inhibit T lymphocyte proliferation. Immunol. Lett. 19:1988;7-13.
7. Cianciolo G.J., Copeland T.D., Oroszlan S., Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 230:1985;453-455.
8. Denner J. How does HIV induce AIDS? The virus protein hypothesis. J. Hum. Virol. 3:2000;81-82.
9. Denner J., Norley S., Kurth R. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. AIDS. 8:1994;1063-1072.
10. Endo K., Oki E., Biedermann V., Kojima H., Yoshida K., Johannes F.J.et al. Proteolytic cleavage and activation of protein kinase Cμ by caspase-3 in the apoptotic response of cells to 1-β-D-arabinofuranosylcytosine and other genotoxic agents. J. Biol. Chem. 275:2000;18476-18481.
11. Haraguchi S., Cianciolo G.J., Good R.A., James-Yarish M., Brigino E., Day N.K. Inhibition of interleukin-2 and interferon-γ by an HIV-1 Nef-encoded synthetic peptide. AIDS. 12:1998;820-823.
12. Haraguchi S., Good R.A., Cianciolo G.J., Engelman R.W., Day N.K. Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections. J. Leukoc. Biol. 61:1997;654-666.
13. Haraguchi S., Good R.A., Day N.K. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today. 16:1995;595-603.
14. Haraguchi S., Good R.A., James-Yarish M., Cianciolo G.J., Day N.K. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5568-5571.
15. Hausser A., Storz P., Hubner S., Braendlin I., Martinez-Moya M., Link G.et al. Protein kinase Cμ selectively activates the mitogen-activated protein kinase (MAPK) p42 pathway. FEBS Lett. 492:2001;39-44.
16. Haussermann S., Kittstein W., Rincke G., Johannes F.J., Marks F., Gschwendt M. Proteolytic cleavage of protein kinase Cμ upon induction of apoptosis in U937 cells. FEBS Lett. 462:1999;442-446.
17. Haworth R.S., Goss M.W., Rozengurt E., Avkiran M. Expression and activity of protein kinase D/protein kinase Cμ in myocardium: evidence for α1-adrenergic receptor- and protein kinase C-mediated regulation. J. Mol. Cell Cardiol. 32:2000;1013-1023.
18. Huang S.S., Huang J.S. A pentacosapeptide (CKS-25) homologous to retroviral envelope proteins possesses a transforming growth factor-β activity. J. Biol. Chem. 273:1998;4815-4818.
19. Iglesias T., Waldron R.T., Rozengurt E. Identification of in vitro phosphorylation sites required for protein kinase D activation. J. Biol. Chem. 273:1998;27662-27667.
20. Jamora C., Yamanouye N., Van Lint J., Laudenslager J., Vandenheede J.R., Faulkner D.J.et al. Gβγ-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell. 98:1999;59-68.
21. Johannes F.J., Horn J., Link G., Haas E., Siemienski K., Wajant H.et al. Protein kinase Cμ downregulation of tumor-necrosis-factor-induced apoptosis correlates with enhanced expression of nuclear-factor-κB-dependent protective genes. Eur. J. Biochem. 257:1998;47-54.
22. Johannes F.J., Prestle J., Eis S., Oberhagemann P., Pfizenmaier K. PKCμ is a novel, atypical member of the protein kinase C family. J. Biol. Chem. 269:1994;6140-6148.
23. Li X., McDermott B., Yuan B., Goff S.P. Homomeric interactions between transmembrane proteins of Moloney murine leukemia virus. J. Virol. 70:1996;1266-1270.
24. Liljedahl M., Maeda Y., Colanzi A., Ayala I., Van Lint J., Malhotra V. Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell. 104:2001;409-420.
25. Liu W.S., Heckman C.A. The sevenfold way of PKC regulation. Cell. Signal. 10:1998;529-542.
26. Matthews S.A., Rozengurt E., Cantrell D. Protein kinase D: a selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J. Exp. Med. 191:2000;2075-2082.
27. Newton A.C. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors and macromolecular interactions. Chem. Rev. 101:2001;2353-2364.
28. Paolucci L., Rozengurt E. Protein kinase D in small cell lung cancer cells: rapid activation through protein kinase C. Cancer Res. 59:1999;572-577.
29. Parekh D.B., Ziegler W., Parker P.J. Multiple pathways control protein kinase C phosphorylation. EMBO J. 19:2000;496-503.
30. Prestle J., Pfizenmaier K., Brenner J., Johannes F.J. Protein kinase C μ is located at the Golgi compartment. J. Cell Biol. 134:1996;1401-1410.
31. Rey O., Young S.H., Cantrell D., Rozengurt E. Rapid protein kinase D translocation in response to G protein-coupled receptor activation Dependence on protein kinase C. J. Biol. Chem. 276:2001;32616-32626.
32. Ruegg C.L., Monell C.R., Strand M. Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. J. Virol. 63:1989;3250-3256.
33. Ruegg C.L., Monell C.R., Strand M. Inhibition, of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J. Virol. 63:1989;3257-3260.
34. Ruegg C.L., Strand M. Identification of a decapeptide region of human interferon-α with antiproliferative activity and homology to an immunosuppressive sequence of the retroviral transmembrane protein P15E. J. Interferon Res. 10:1990;621-626.
35. Sidorenko S.P., Law C.L., Klaus S.J., Chandran K.A., Takata M., Kurosaki T.et al. Protein kinase C μ (PKCμ) associates with the B cell antigen receptor complex and regulates lymphocyte signaling. Immunity. 5:1996;353-363.
36. Smith R.J., Sam L.M., Justen J.M., Bundy G.L., Bala G.A., Bleasdale J.E. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J. Pharmacol. Exp. Ther. 253:1990;688-697.
37. Takahashi A., Day N.K., Luangwedchakarn V., Good R.A., Haraguchi S. A retroviral-derived immunosuppressive peptide activates mitogen-activated protein kinases. J. Immunol. 166:2001;6771-6775.
38. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M.et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
39. Van Lint J., Ni Y., Valius M., Merlevede W., Vandenheede J.R. Platelet-derived growth factor stimulates protein kinase D through the activation of phospholipase Cγ and protein kinase C. J. Biol. Chem. 273:1998;7038-7043.
40. Van Lint J., Rykx A., Maeda Y., Vantus T., Sturany S., Malhotra V.et al. Protein kinase D: an intracellular traffic regulator on the move. Trends Cell. Biol. 12:2002;193-200.
41. 748 in protein kinase D are transphosphorylated in vivo. J. Biol. Chem. 276:2001;32606-32615.
42. Wang H., Nishanian P., Fahey J.L. Characterization of immune suppression by a synthetic HIV gp41 peptide. Cell Immunol. 161:1995;236-243.
43. Wei E.T., Thomas H.A. Anti-inflammatory peptide agonists. Annu. Rev. Pharmacol. Toxicol. 33:1993;91-108.
44. Zugaza J.L., Waldron R.T., Sinnett-Smith J., Rozengurt E. Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway. J. Biol. Chem. 272:1997;23952-23960.